Memento Medicines Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $93M

  • Investors
  • 5

Memento Medicines General Information

Description

Developer of antibody-based therapeutics designed to treat retinal and vascular diseases. The company develops bispecific antibody therapies that activate Tie2 signaling and inhibit VEGF pathways, enabling the treatment of conditions such as neovascular age-related macular degeneration and diabetic macular edema.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Boston, MA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Boston, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Memento Medicines Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 18-Jun-2026 $93M Completed Pre-Clinical Trials
To view Memento Medicines’s complete valuation and funding history, request access »

Memento Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
To view Memento Medicines’s complete cap table history, request access »

Memento Medicines Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Avego Management PE/Buyout Minority
Forbion Venture Capital Minority
RA Capital Management Asset Manager Minority
Samsara BioCapital Venture Capital Minority
Sanofi Ventures Corporate Venture Capital Minority
To view Memento Medicines’s complete investors history, request access »

Memento Medicines FAQs

  • When was Memento Medicines founded?

    Memento Medicines was founded in 2026.

  • Where is Memento Medicines headquartered?

    Memento Medicines is headquartered in Boston, MA.

  • What industry is Memento Medicines in?

    Memento Medicines’s primary industry is Drug Discovery.

  • Is Memento Medicines a private or public company?

    Memento Medicines is a Private company.

  • What is the current valuation of Memento Medicines?

    The current valuation of Memento Medicines is .

  • What is Memento Medicines’s current revenue?

    The current revenue for Memento Medicines is .

  • How much funding has Memento Medicines raised over time?

    Memento Medicines has raised $93M.

  • Who are Memento Medicines’s investors?

    Avego Management, Forbion, RA Capital Management, Samsara BioCapital, and Sanofi Ventures have invested in Memento Medicines.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process